Lichter Jay
SEC CIK 1376355 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Dir, 10% | 8,868 | $4.99M | $82.30M | 5 | 2023-11-13 | 2024-09-13 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
Lichter Jay made no open-market trades at JANX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-24 | 2024-09-13 | JANX | Janux Therapeutics, Inc. | Lichter Jay | 10% | M - OptEx | $17.29 | +3,815 | 8,868 | +75% | +$66.0K |
| D | 2024-10-24 | 2024-09-13 | JANX | Janux Therapeutics, Inc. | Lichter Jay | 10% | S - Sale+OE | $46.68 | -3,815 | 7,000 | -35% | -$178.1K |
| D | 2024-06-28 | 2024-06-26 | JANX | Janux Therapeutics, Inc. | Lichter Jay | Dir, 10% | A - Grant | $0.00 | +2,500 | 7,083 | +55% | $0 |
| MI | 2024-06-05 | 2024-06-03 | JANX | Janux Therapeutics, Inc. | Lichter Jay | Dir, 10% | S - Sale | $54.75 | -1.50M | 3.34M | -31% | -$82.12M |
| I | 2023-11-15 | 2023-11-13 | JANX | Janux Therapeutics, Inc. | Lichter Jay | Dir, 10% | P - Purchase | $5.87 | +849.9K | 849.9K | New | +$4.99M |
Purchase Sale Sale after option exercise All abbreviations